These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 3724227
21. High-volume crystalloid cardioplegia. An improved method of myocardial preservation. Engelman RM, Rousou JH, Lemeshow S. J Thorac Cardiovasc Surg; 1983 Jul; 86(1):87-96. PubMed ID: 6602916 [Abstract] [Full Text] [Related]
22. Multidose blood versus crystalloid cardioplegia. Comparison by quantitative assessment of irreversible myocardial injury. Feindel CM, Tait GA, Wilson GJ, Klement P, MacGregor DC. J Thorac Cardiovasc Surg; 1984 Apr; 87(4):585-95. PubMed ID: 6708578 [Abstract] [Full Text] [Related]
23. Reduced oxygen consumption with effective left ventricular venting during postischemic reperfusion. Kanter KR, Schaff HV, Gott VL, Gardner TJ. Circulation; 1982 Aug; 66(2 Pt 2):I50-4. PubMed ID: 7083546 [Abstract] [Full Text] [Related]
24. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia. Lu K, Otani H, Yamamura T, Nakao Y, Hattori R, Ninomiya H, Osako M, Imamura H. J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170 [Abstract] [Full Text] [Related]
25. Effect of small-amplitude electrical activity on myocardial preservation in the cold potassium-arrested heart. Landymore RW, Marble AE, Trillo A, MacAulay M, Faulkner G, Cameron C. J Thorac Cardiovasc Surg; 1986 May; 91(5):684-9. PubMed ID: 3702477 [Abstract] [Full Text] [Related]
26. Ischemic myocardial protection. Comparison of nonoxygenated crystalloid, oxygenated crystalloid, and oxygenated fluorocarbon cardioplegic solutions. Tabayashi K, McKeown PP, Miyamoto M, Luedtke AE, Thomas R, Allen MD, Misbach GA, Ivey TD. J Thorac Cardiovasc Surg; 1988 Feb; 95(2):239-46. PubMed ID: 3339891 [Abstract] [Full Text] [Related]
27. Effects of left ventricular venting and distention during heterogenous distribution of cardioplegic solution. Lazar HL, Wilcox K, Hankins T, Plehn J, Roberts AJ. J Thorac Cardiovasc Surg; 1988 Mar; 95(3):501-7. PubMed ID: 3343857 [Abstract] [Full Text] [Related]
28. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas' and histidine-tryptophan-ketoglutarate cardioplegia--an experimental comparative study in pigs. Aarsaether E, Stenberg TA, Jakobsen Ø, Busund R. Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):635-9. PubMed ID: 19628529 [Abstract] [Full Text] [Related]
34. Advantages of hypothermic potassium cardioplegia and superiority of continuous versus intermittent aortic cross-clamping. Roberts AJ, Abel RM, Alonso DR, Subramanian VA, Paul JS, Gay WA. J Thorac Cardiovasc Surg; 1980 Jan; 79(1):44-58. PubMed ID: 7350388 [Abstract] [Full Text] [Related]
35. Effect of reperfusion temperature and pressure on the functional and metabolic recovery of preserved hearts. Swanson DK, Myerowitz PD. J Thorac Cardiovasc Surg; 1983 Aug; 86(2):242-51. PubMed ID: 6876860 [Abstract] [Full Text] [Related]
36. Effect of an oxygen-enriched solution and multiple dosing of antegrade crystalloid cardioplegic solution on myocardial metabolism during coronary artery bypass graft operations. Downey RS, Weintraub WS, Jones EL, Conn RB, Ash T. J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1148-7. PubMed ID: 1405675 [Abstract] [Full Text] [Related]